Crossmark

The use of 3′-deoxy-3′-18F-fluorothymidine (FLT) PET in the assessment of long-term survival in breast cancer patients treated with neoadjuvant chemotherapy

Crossref DOI link: https://doi.org/10.1007/s12149-019-01345-w

Published Online: 2019-02-27

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ueberroth, Benjamin E. https://orcid.org/0000-0001-8882-2348
Lawhorn-Crews, Jawana M.

Heilbrun, Lance K.

Smith, Daryn W.

Akoury, Janice

Ali-Fehmi, Rouba

Eiseler, Nicole T.

Shields, Anthony F.
License Information

Text and Data Mining valid from 2019-02-27
More Information

Article History

Received: 8 November 2018

Accepted: 21 February 2019

First Online: 27 February 2019

Document is current

Any future updates will be listed below